Travere Therapeutics, Inc. TVTX
50.35 USD -0.30 (-0.59%)
As ofNov 16, 2026, 10:48 AM EST
49.95 Day range 51.00
22.59 52-week range 68.73
- YTD
- +31.77%
- 1 year
- +45.94%
Next earnings
Feb 18, 2027
Expected Feb 18, 2027. Consensus EPS estimate 0.8028.
Included in Essentials and up
Sign in to see Estimates and results by quarter
Analyst estimates for the coming quarters next to what the company reported.
Earnings history
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 18, 2027 | Dec 30, 2026 | 0.4397 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | -0.05545 | -0.55 | -0.49 | -891.88% |
| Aug 4, 2026 | Jun 30, 2026 | -0.13465 | -0.37 | -0.24 | -174.79% |
| May 4, 2026 | Mar 31, 2026 | -0.30 | -0.39 | -0.09 | -30.00% |
| Feb 19, 2026 | Dec 31, 2025 | 0.03 | 0.03 | 0.00 | 0.00% |
| Oct 30, 2025 | Sep 30, 2025 | -0.31 | 0.28 | +0.59 | +190.32% |
